Home
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Clinical trial condition

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Explore clinical trials studying Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Study availability and eligibility vary by location and protocol.

600 public trials 70 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results

Enrolling by Invitation

Observational Study on Dose Optimization of Olverembatinib in Patients With Chronic Myeloid Leukemia in Chronic or Accelerated Phase

NCT07383298

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Enrolling by Invitation

Long-term Risk of Second Primary Malignancies for Chronic Myeloid Leukaemia in the French Imatinib-based SPIRIT Trial

NCT06646978

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia (CML), +11 more
Locations: CHU de Poitiers Poitiers, France

View Trial Details

Not Yet Recruiting

A Study of Asciminib Safety and Efficacy in Young Adults With Chronic Myeloid Leukemia in the Gulf Region

NCT07681258

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study of Patient Characteristics, Co-Morbidities, and Treatment Patterns in Chronic Myeloid Leukemia Patients in Kuwait

NCT07454850

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies

NCT07710781

Conditions: Acute Biphenotypic Leukemia, Acute Leukemia, Acute Lymphoblastic Leukemia, +42 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT

NCT07254793

Conditions: Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Acute Undifferentiated Leukemia (AUL), +31 more
Locations: The University of Arizona Cancer Center Tucson, Arizona, United States

View Trial Details

Not Yet Recruiting

Efficacy of Asciminib in Real-world in Patients With Chronic Myeloid Leukemia in Second or Subsequent Lines

NCT07640750

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

NCT07269470

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations: The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Not Yet Recruiting

ASCiminib, With or Without Dasatinib Combination, as a 2nd-Line Therapy to ADVANCE the Treatment for Chronic Myelogenous Leukemia in Chronic Phase (ASC2ADVANCE)

NCT07538401

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia (CML) in, +11 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT

NCT07302776

Conditions: Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +21 more
Locations: Stanford University Palo Alto, California, United States

View Trial Details

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results

Related conditions